Neurocrine Biosciences, Inc.

About Neurocrine Biosciences, Inc.

Neurocrine Biosciences is a neuroscience-focused biopharmaceutical company headquartered in San Diego, California. Founded in 1992, it discovers, develops, and commercializes treatments for neurological, endocrine, and psychiatric disorders. Approved products address tardive dyskinesia, Parkinson’s disease, endometriosis, and uterine fibroids. The company advances multiple late-stage and early-stage programs targeting essential tremor, epilepsy, congenital adrenal hyperplasia, and schizophrenia, leveraging deep expertise in receptor and ion channel biology.